Withings unveils Go activity tracker with e-ink display for $70, runs 8 months on a button cell battery, can be clip-on or wrist-worn, available Q1 2016
Valentina Palladino / Ars Technica :
Context & Ripple Effects
Withings spent two years walking its analog fitness line downmarket before the Go: the Swiss-made Activité launched at $450 and was dinged in review as too expensive for the mass market, followed by a $150 Pop and a $170 Activite Steel. The Go's $70 price, clip-on-or-wrist form factor, and eight-month button-cell battery are the logical floor of that ladder — a tracker priced like an accessory rather than a watch.
The design bet is notable because e-ink plus long battery life is exactly what Verily's health-research watch prototype pairs together months later, suggesting the trade-off (no rich notifications, near-constant tracking) is aimed at continuous data collection rather than smartwatch-style interaction.
First-order effects
- Withings now fields a sub-$100 entry point beneath its own $150-$200 analog watches, letting it capture buyers unwilling to spend Activite Steel money while keeping them inside Withings' app ecosystem.
- The clip-on option puts the same hardware in competition with pocketable trackers rather than just wristbands, widening the addressable use cases without a second product line.
Second-order effects
- Rivals selling screen-based bands must justify their higher prices against a device whose battery lasts months on a coin cell, shifting the comparison from features to total cost of ownership.
- A cheap, always-worn tracker functions as a funnel: owners who get used to Withings tracking are the natural market for its pricier heart-rate and clinical-grade follow-ons, like the later Move ECG smartwatch built around pending FDA clearance.
Third-order effects
- If e-ink-and-button-cell designs keep proving out — Verily's prototype points the same direction for medical research wearables — the category splits structurally into cheap always-on sensors feeding data services and premium clinical devices, rather than converging on one do-everything smartwatch.
- That split favors companies that own both ends of the line and the data layer between them, pushing smaller band-makers toward commodity hardware or acquisition.
The trend: Wearables are bifurcating into inexpensive, long-battery-life passive trackers and pricier clinically oriented smartwatches, with Withings deliberately spanning both.